Early Hemodynamic Changes Based on Initial Color-Coding Angiography as a Predictor for Developing Subsequent...

Despite advances in neuroimaging, predicting vasospasm after aneurysmal subarachnoid hemorrhage remains challenging. Current methods rely on clinical and radiographic features, but these do not always capture early hemodynamic shifts. Prior research has shown that delayed vasospasm contributes to poor outcomes in these patients. However, no prior work had resolved whether early changes in cerebral blood flow could improve risk stratification. This gap motivated the current study to explore hemodynamic markers from initial angiography. Understanding these early indicators could refine patient management strategies. No prior work had resolved the predictive value of peak time and mean transit time measurements. These parameters may reflect early vascular dysfunction before clinical symptoms appear. This uncertainty drove the need for a more precise, quantitative approach.

The aim of this study was to determine whether early hemodynamic changes on initial color-coding angiography could predict the development of delayed vasospasm after aneurysmal subarachnoid hemorrhage. Researchers focused on whether peak time and mean transit time measurements could serve as early indicators. They hypothesized that these parameters might reflect vascular stress before clinical signs emerge. The study sought to compare these metrics between patients with and without delayed vasospasm. A control group of patients with unruptured aneurysms was included for comparison. Researchers wanted to assess whether these hemodynamic features could improve risk prediction. They also aimed to evaluate the timing of these changes relative to aneurysm rupture. This could help guide early intervention strategies to prevent complications.

The study included 53 patients with aneurysmal subarachnoid hemorrhage and 12 with unruptured intracranial aneurysms. All participants underwent initial color-coding angiography at admission. Researchers collected clinical and radiologic data for analysis. They used uni- and multivariate statistical methods to evaluate associations. The primary outcome was the occurrence of delayed vasospasm. Hemodynamic features such as peak time and mean transit time were measured. Researchers compared these values between patients with and without delayed vasospasm. They also controlled for age, Hunt and Hess grade, and modified Fisher grade.

Of the 53 patients with aneurysmal subarachnoid hemorrhage, 37 (70%) developed delayed vasospasm. Patients with delayed vasospasm had a shorter peak time in the anterior cerebral artery A2 segment (P = 0.036). They also showed shorter peak times in the middle cerebral artery M1 (P = 0.045) and M3 (P = 0.013) segments. The mean transit time from the internal carotid artery to the middle cerebral artery M3 segment was also shorter (P = 0.026). These differences remained significant after adjusting for clinical variables. No such associations were found in the control group with unruptured aneurysms. The study found no significant differences in other hemodynamic parameters. These results suggest that early hemodynamic changes may predict delayed vasospasm. The findings were based on measurements taken within 48 hours of aneurysm rupture.

The authors propose that early hemodynamic changes on initial color-coding angiography may predict the development of delayed vasospasm after aneurysmal subarachnoid hemorrhage. These changes include shorter peak times and mean transit times in specific cerebral artery segments. The study suggests that these parameters could improve risk stratification for delayed vasospasm. The findings were significant after controlling for age and clinical severity scores. Researchers propose that these markers may reflect early vascular dysfunction. They suggest that early identification could help guide aggressive prophylactic therapy. The study supports the use of quantitative hemodynamic assessments in patient management. These results may help clinicians identify high-risk patients earlier.